ARX vs CMP

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

56MEDIUM

CMP

COMPUMEDIC FPO [CMP]

54MEDIUM

Score Breakdown

ARX CMP
Technical
48
32
Catalyst
55
54
Sentiment
50
50
Fundamental
99
85
Momentum
46
47
Risk Gate
50
47

Key Metrics

ARX Metric CMP
$191.1MMarket Cap$54.9M
144KAvg Volume (20d)65K
N/AShort InterestN/A
$0.80052-Week High$0.450
$0.49552-Week Low$0.215
+0.0%Daily Change-14.6%
$0.540Reference Price$0.235
+4.9%ROE+1.0%
+4.5%Profit Margin+0.3%

Active Signals

ARX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 4.4% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it

CMP Signals

Volume surging at 4.7x normal while price falls — heavy selling pressure
Drifting lower — down 7.8% over the last 5 days
Volatility is expanding fast — choppy price action, so buckle up
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.9x)
Moderate revenue growth (+12%)
Piotroski F-Score strong (7/9, low-confidence approx)

Ask Scout AI to compare ARX and CMP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs PIQ →ATX vs CMP →ATX vs EPI →ATX vs PHX →ATX vs PIQ →
ARX Full Analysis → CMP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).